PubMedCrossRef 50. Sohaskey CD, Zuckert WR, Barbour AG: The extended promoters for two outer membrane lipoprotein genes of Borrelia spp. uniquely include a T-rich region. Mol Microbiol 1999,33(1):41–51.PubMedCrossRef 51. Hodzic E, Tunev S, Feng S, Freet KJ, Barthold SW: Immunoglobulin-regulated expression of Borrelia burgdorferi

outer surface protein A in vivo. Infect Immun 2005,73(6):3313–3321.PubMedCrossRef 52. Srivastava SY, de Silva AM: Reciprocal expression of ospA and ospC in single cells of Borrelia burgdorferi . J Bacteriol 2008,190(10):3429–3433.PubMedCrossRef 53. Kalish RA, Leong JM, Steere AC: Early and late antibody responses to full-length and truncated constructs Epigenetics inhibitor of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun 1995,63(6):2228–2235.PubMed

54. Schutzer SB525334 mouse SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M: Early and specific antibody response to OspA in Lyme Disease. J Clin Invest 1994,94(1):454–457.PubMedCrossRef 55. Liang FT, Caimano MJ, Radolf JD, Fikrig E: Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA . Microb Pathog 2004,37(1):35–40.PubMedCrossRef 56. Xu Q, McShan K, Liang FT: Two regulatory elements required for enhancing ospA expression in Borrelia burgdorferi grown in vitro but repressing its expression during mammalian infection. Microbiology 2010,156(Pt 7):2194–2204.PubMedCrossRef 57. Gern L, Schaible UE, Simon MM: Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect

Dis 1993,167(4):971–975.PubMedCrossRef 58. Barbour AG, Burgdorfer W, Grunwaldt E, Steere AC: Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest 1983,72(2):504–515.PubMedCrossRef 59. Krause A, Burmester GR, Rensing A, Schoerner C, Schaible UE, Simon MM, Herzer P, Kramer MD, Wallich R: Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest 1992,90(3):1077–1084.PubMedCrossRef 60. Blevins JS, Hagman KE, Norgard Vildagliptin MV: Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol 2008, 8:82.PubMedCrossRef 61. Coburn J: Adhesion mechanisms of the Lyme disease spirochete, Borrelia burgdorferi . Curr Drug Targets Infect Disord 2001,1(2):171–179.PubMedCrossRef 62. Guo BP, Norris SJ, Rosenberg LC, Hook M: Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun 1995,63(9):3467–3472.PubMed 63. Hagman KE, Yang X, Wikel SK, Schoeler GB, Caimano MJ, Radolf JD, Norgard MV: Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect Immun 2000,68(8):4759–4764.PubMedCrossRef 64.